Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-02-06T11:14:39.909Z Has data issue: false hasContentIssue false

Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis

Published online by Cambridge University Press:  16 May 2011

D. Collip
Affiliation:
Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands
N. A. Nicolson
Affiliation:
Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands
M. Lardinois
Affiliation:
Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands
T. Lataster
Affiliation:
Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands
J. van Os
Affiliation:
Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands King's College London, King's Health Partners, Department of Psychosis Studies, Institute of Psychiatry, London, UK
I. Myin-Germeys*
Affiliation:
Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands
*
*Address for correspondence: Prof. Dr. I. Myin-Germeys, Department of Psychiatry and Neuropsychology, Maastricht University, PO Box 616 (VIJV1), 6200 MD Maastricht, The Netherlands. (Email: i.germeys@maastrichtuniversity.nl)
Rights & Permissions [Opens in a new window]

Abstract

Background

Hypothalamic-pituitary-adrenocortical (HPA) axis abnormalities have been found in patients with a psychotic disorder and first-degree relatives of patients with a psychotic disorder react with subtle increases in non-clinical psychotic experiences and negative emotions in the face of everyday stress. The current study investigated whether HPA axis functioning is altered in individuals at above average genetic risk for psychotic disorder, examining diurnal cortisol profiles, cortisol reactivity to daily stressors and the association between HPA axis activity and subclinical psychotic experiences.

Method

Participants included siblings of patients with a psychotic disorder (n=60) and a healthy comparison group (n=63). The Experience Sampling Method (a structured diary technique) was employed to assess stress, psychotic experiences, negative affect and salivary cortisol repeatedly in the flow of daily life.

Results

Multi-level analyses revealed higher diurnal cortisol levels and heightened cortisol reactivity to negative daily events in siblings compared with controls. Diurnal cortisol slope did not differ between the two groups, but momentary increases in psychotic experiences and negative affect were associated with increased cortisol in the sibling group.

Conclusions

Findings support altered HPA axis activity in individuals at above average genetic risk for psychotic disorder, as evidenced by higher diurnal cortisol levels and increased cortisol reactivity to daily stress. Results also suggest a dynamic association between cortisol secretion and the intensity of psychotic-like experiences and negative emotions in daily life, although the direction of this association remains to be elucidated.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2011

Introduction

Minor stresses in the flow of daily life have repeatedly been associated with increases in psychotic symptoms and negative emotions in individuals with a psychotic disorder (Myin-Germeys et al. Reference Myin-Germeys, Delespaul and van Os2005a). However, the biological substrate underlying this phenomenon remains unknown and vulnerability markers need to be identified. Results of experimental studies suggest that increased psychotic reactivity to stress may reflect increased dopamine reactivity (Myin-Germeys et al. Reference Myin-Germeys, Marcelis, Krabbendam, Delespaul and van Os2005b; Soliman et al. Reference Soliman, O'Driscoll, Pruessner, Holahan, Boileau, Gagnon and Dagher2008). In addition, several lines of evidence indicate that dysregulation of the hypothalamic-pituitary-adrenocortical (HPA) axis may play a role in the relationship between stress and psychotic experiences (van Winkel et al. Reference van Winkel, Stefanis and Myin-Germeys2008; Walker et al. Reference Walker, Mittal and Tessner2008). In individuals with a psychotic disorder, abnormalities have been found at various levels of the HPA axis, including functional and structural changes in the hypothalamus (Koolschijn et al. Reference Koolschijn, van Haren, Hulshoff Pol and Kahn2008), the pituitary (Pariante, Reference Pariante2008) and the hippocampus (Wright et al. Reference Wright, Rabe-Hesketh, Woodruff, David, Murray and Bullmore2000). Similarly, cortisol levels and reactivity to stress may be disturbed (Albus et al. Reference Albus, Ackenheil, Engel and Muller1982; Breier et al. Reference Breier, Wolkowitz, Doran, Bellar and Pickar1988; Jansen et al. Reference Jansen, Gispen-de Wied, Gademan, De Jonge, van der Linden and Kahn1998; Jansen et al. Reference Jansen, Gispen-de Wied and Kahn2000; Marcelis et al. Reference Marcelis, Cavalier, Gielen, Delespaul and van Os2004; Ryan et al. Reference Ryan, Sharifi, Condren and Thakore2004; Walsh et al. Reference Walsh, Spelman, Sharifi and Thakore2005; Brenner et al. Reference Brenner, Liu, Laplante, Lupien, Pruessner, Ciampi, Joober and King2009; Mondelli et al. Reference Mondelli, Dazzan, Hepgul, di Forti, Aas, d'Albenzio, di Nicola, Fisher, Handley, Marques, Morgan, Navari, Taylor, Papadopoulos, Aitchison, Murray and Pariante2010). Nevertheless, it remains uncertain whether HPA axis abnormalities are causally related to the increased emotional and psychotic stress reactivity observed in patients with a psychotic disorder.

One of the major obstacles to research in this area is that patients with a psychotic disorder usually receive antipsychotic medication, which can affect cortisol levels and brain structures (Meltzer et al. Reference Meltzer, Koenig, Nash and Gudelsky1989; Wik, Reference Wik1995; Pariante, Reference Pariante2008). Thus, studies in patient samples cannot yield firm conclusions about HPA axis dysregulation as a biological substrate or vulnerability marker. Studies in patients with a first episode of psychotic illness are informative in that they are not confounded by long-term medication or illness effects. However, they cannot establish the degree to which increased HPA axis activity constitutes a precursor of psychosis, as reflected in an increased vulnerability to stress, as opposed to being the result of the psychosis and related stress. Therefore, studies have been conducted in persons who are prone to psychosis but have not developed a psychotic disorder. Schizotypal adolescents, for example, were found to have higher cortisol levels than controls (Mittal et al. Reference Mittal, Dhruv, Tessner, Walder and Walker2007) and heightened cortisol secretion in another sample of schizotypal adolescents was associated with schizotypal symptomatology at 2-year follow-up (Walker et al. Reference Walker, Walder and Reynolds2001). The potential predictive value of HPA axis abnormalities is further supported by findings in a sample of young people at ultra-high risk of psychotic disorder; months before onset, those who later developed a psychotic disorder had larger pituitary volumes than those who did not develop a disorder (Garner et al. Reference Garner, Pariante, Wood, Velakoulis, Phillips, Soulsby, Brewer, Smith, Dazzan, Berger, Yung, van den Buuse, Murray, McGorry and Pantelis2005). Walker et al. (Reference Walker, Brennan, Esterberg, Brasfield, Pearce and Compton2010) recently reported that higher cortisol levels predicted higher risk of conversion to psychotic disorder in an at-risk sample studied longitudinally. Together, these findings add support to the hypothesis that heightened stress reactivity may be one of the risk factors underlying both HPA axis abnormalities and vulnerability to psychotic disorder.

Healthy siblings of individuals with a psychotic disorder are another important research population: they share not only genetic vulnerability for psychosis with their affected siblings, but also many sociodemographic, parental and developmental characteristics. First-degree relatives show increases in the intensity of subtle psychotic experiences and negative emotions in reaction to daily hassles (Myin-Germeys et al. Reference Myin-Germeys, van Os, Schwartz, Stone and Delespaul2001b, 2005 a). Moreover, studies have reported structural HPA axis abnormalities, such as increased pituitary (Mondelli et al. Reference Mondelli, Dazzan, Gabilondo, Tournikioti, Walshe, Marshall, Schulze, Murray, McDonald and Pariante2008) and hypothalamic volumes (Goldstein et al. Reference Goldstein, Seidman, Makris, Ahern, O'Brien, Caviness, Kennedy, Faraone and Tsuang2007), in relatives of patients with schizophrenia. However, sibling studies have not yet examined cortisol secretory patterns or the possible association of cortisol with increased emotional and psychotic reactivity to stress in daily life.

The current study, therefore, assessed cortisol in a sample of siblings of patients with psychotic disorder and matched controls. We used the Experience Sampling Method (ESM), a structured diary technique, to assess daily hassles, psychotic experiences and negative emotions at frequent intervals over the course of several days, with concurrent sampling of salivary cortisol. In studies conducted in the natural environment, cortisol is generally characterized in terms of overall levels, diurnal patterns and reactivity to acute stressors (Nicolson, Reference Nicolson, Luecken and Gallo2007). Cortisol has a pronounced circadian rhythm, with a sharp increase in the first hour after awakening and a gradual decrease over the rest of the day. Acute stressors can induce short-term peaks, with a half-life of approximately 1 h. The design of the current study allowed investigation of several of these aspects of cortisol secretion. The aims were threefold: (i) to examine differences in overall cortisol levels and diurnal slope between siblings and controls; (ii) to investigate differences between siblings and controls in cortisol reactivity in response to naturally occurring stressors; (iii) to determine the association between momentary psychotic experiences or negative emotions and momentary cortisol in siblings compared with controls. In case of significant group differences, we performed additional analyses to explore alternative (non-genetic) explanations of any difference in cortisol patterns (including effects of depression, childhood trauma, current stress and distress levels and degree of psychometric psychosis liability).

Method

Participants

The sample consisted of 71 healthy siblings (68 full siblings and three half-siblings) of patients diagnosed with a non-affective psychotic disorder and 66 control subjects. The siblings were recruited through their ill relatives or family support organizations as part of a larger study (G.R.O.U.P., 2010). Controls were selected through random mailings to addresses in the residential areas of patients and siblings. Written informed consent, conforming to local ethics committee guidelines, was obtained from all subjects. The Comprehensive Assessment of Symptoms and History (Andreasen et al. Reference Andreasen, Flaum and Arndt1992) was completed to assess symptom history over the past 6 months and lifetime, yielding DSM-IV diagnoses (APA, 1994). Inclusion criteria were: (i) age 16–55 years; (ii) sufficient command of the Dutch language. Exclusion criteria were: (i) use of steroid medication; (ii) current Axis 1 disorder; (iii) lifetime history of psychotic disorder; and, for the controls, (iv) family history of psychotic disorder as assessed by the FIGS (NIMH Genetics Initiative, 1992).

ESM

The ESM is a random time-sampling self-assessment technique; studies have demonstrated the feasibility, validity and reliability of ESM in general and patient populations (Csikszentmihalyi & Larson, Reference Csikszentmihalyi and Larson1987; Myin-Germeys et al. Reference Myin-Germeys, Oorschot, Collip, Lataster, Delespaul and van Os2009). Subjects received a digital wristwatch that emitted a signal 10 times per day on six consecutive days, at unpredictable moments between 07:30 and 22:30 hours. After each ‘beep’, subjects completed ESM self-assessment forms concerning current context, thoughts, emotions and psychotic experiences. Subjects were instructed to complete their reports immediately after the beep, thus minimizing memory distortions. Reports were considered valid when subjects responded within 15 min after the beep, as determined by comparing the actual beep time with the reported time of completion. For inclusion in the analyses, participants had to have provided valid responses to at least one-third of the emitted beeps (Delespaul et al. Reference Delespaul, deVries and van Os2002).

Salivary cortisol sampling

After each ESM beep, subjects collected a saliva sample with a cotton swab (Salivette; Sarstedt, The Netherlands), replaced the swab in the salivette tube, and recorded the exact collection time. Samples were stored in subjects' home freezers until transport to the laboratory, where uncentrifuged samples were kept at −20°C until analysis. Saliva samples collected more than 15 min after the beep were excluded from the analysis.

ESM measures

Event stress

Stress was conceptualized in terms of subjective appraisals of events and minor disturbances that continually occur in the natural flow of daily life. After each beep, participants were asked to report the most important event that had happened between the current and the previous report and then to rate this event on a 7-point, bipolar Likert scale (−3=very unpleasant, 0=neutral, 3=very pleasant). For the current analyses, all positive responses were recoded as 0 and the negative responses were recoded so that high scores reflect more unpleasant and potentially stressful events (0=neutral, 3=very unpleasant) (Jacobs et al. Reference Jacobs, Myin-Germeys, Derom, Delespaul, van Os and Nicolson2007).

Psychotic experiences

Psychotic symptomatology was assessed with eight ESM items rated on 7-point Likert scales (1=not at all to 7=very): ‘My thoughts are now paranoid’, ‘My thoughts are difficult to express’, ‘I can't get rid of my thoughts’, ‘My thoughts are influenced by other people’, ‘I feel unreal’, ‘I hear voices’, ‘I see things’ and ‘I am afraid of losing control’ (Myin-Germeys et al. Reference Myin-Germeys, Delespaul and van Os2005a). The mean of these eight ratings formed the variable psychotic experiences.

Negative affect

Negative affect was assessed as the mean score on five ESM items, rated on 7-point Likert scales (1=not at all to 7=very): ‘I feel insecure’, ‘I feel lonely’, ‘I feel anxious’, ‘I feel down’ and ‘I feel guilty’.

Salivary cortisol

Salivary cortisol is a reliable and non-invasive measure of the free, unbound cortisol in blood, which is considered to be the biologically active hormone. Radio-immunoassays were run in duplicate, using a tracer solution of cortisol-3CMO coupled with 2-[125 I]histamine and specific antibodies raised against cortisol-3CMO-BSA (Sulon et al. Reference Sulon, Demey-Ponsart, Beauduin and Sodoyez1978) (Dr J. Sulon, University of Liège). The lower detection limit of the assay was 0.2 nmol/l. The intra- and inter-assay coefficients of variation were <5% and <12%, respectively. All samples from an individual were analysed in the same assay to reduce sources of variability. Observations with cortisol >44 nmol/l (n=11) were considered physiologically abnormal and were excluded from the statistical analysis (van Eck et al. Reference van Eck, Berkhof, Nicolson and Sulon1996; Peeters et al. Reference Peeters, Nicolson and Berkhof2004;Jacobs et al. Reference Jacobs, Myin-Germeys, Derom, Delespaul, van Os and Nicolson2007).

Questionnaire measures

Trait psychosis liability

Participants completed the 40-item Community Assessment of Psychic Experiences (CAPE) (Hanssen et al. Reference Hanssen, Bak, Bijl, Vollebergh and van Os2005), a self-report instrument that captures variation in the positive and negative dimensions of non-clinical psychotic experiences as well as variation in depression. The total score on the positive dimension (hereafter CAPE trait score) was used as indicator of psychometric psychosis liability.

Childhood trauma

Participants completed a Dutch version of the Childhood Trauma Questionnaire 25-item short form (CTQ) (Bernstein et al. Reference Bernstein, Stein, Newcomb, Walker, Pogge, Ahluvalia, Stokes, Handelsman, Medrano, Desmond and Zule2003). The CTQ consisted of 25 questions rated on a 5-point Likert scale enquiring about traumatic experiences in childhood. A general measure of childhood trauma was generated by calculating the sum of the answers to all 25 questions.

Statistical analyses

Multi-level modelling approach

Analyses of variance and χ2 tests were conducted to investigate group differences in demographic characteristics, cross-sectional measures and mean ratings on ESM variables. ESM and cortisol data were analysed using multi-level regression techniques, which take the hierarchical structure of the data into account. Altogether, 35 families provided more than one participant, resulting in a further level of clustering. Thus, in the current study, repeated momentary measurements (level 1) were clustered within days (level 2), within subjects (level 3), some of whom were members of the same family (level 4). Data were analysed using the xtmixed multi-level random regression routine in Stata 11.0 (StataCorp, 2009). The β's are the fixed regression coefficients of the predictors in the multi-level model. When significant interactions were found, stratified analyses were conducted to clarify group differences, using the stata lincom command to calculate the appropriate linear combinations.

Cortisol values were log transformed to reduce skewness of distribution, generating the variable lncort. The variable time was centred around the grand mean for all samples. To model the cortisol diurnal curve, the variables time and time2 were included as predictors in all analyses, with lncort as dependent variable; addition of higher order polynomial terms did not improve model fit. The following confounders were examined in all models: gender; age; recent consumption of food or tobacco use (i.e. in the approximately 90 min interval since the previous ESM beep); use of oral contraceptives; recent awakening (samples taken within 60 min of awakening).

Cortisol levels and diurnal slope

To test whether mean cortisol level differed between sibling and control groups, a multi-level model was estimated with lncort as the dependent variable and the categorical variable group (0=controls, 1=siblings) as independent variable. To examine whether familial vulnerability for psychosis was reflected in the diurnal cortisol slope, a group×time interaction term was added to the model.

Cortisol reactivity to daily stressors

To investigate whether stress elicited differential cortisol reactions in the two groups, a multi-level analysis was conducted with lncort as the dependent variable and group, event stress and their interaction as the independent variables.

Association between cortisol, psychotic experiences and negative affect

To examine whether increases in psychotic experiences or negative affect were associated with within-person fluctuations in cortisol, we first conducted multi-level analyses with lncort as the dependent variable and group, psychotic experiences (and respectively negative affect) and their interaction as the independent variables. Next, negative affect and psychotic experiences and their interactions with group were included in the same model to determine whether negative affect might mediate the relationship between momentary psychotic experience and cortisol, given that negative emotions have been associated with both cortisol and psychosis (Myin-Germeys et al. Reference Myin-Germeys, Nicolson and Delespaul2001a; Freeman & Garety, Reference Freeman and Garety2003; Thompson et al. Reference Thompson, Phillips, Komesaroff, Yuen, Wood, Pantelis, Velakoulis, Yung and McGorry2007).

Results

Compliance and sample characteristics

Altogether, 14 participants (11 siblings and three control subjects) were unable to comply adequately with the research protocol (13 filled in fewer than 20 valid reports and one provided no saliva samples) and were therefore excluded from the analyses. The final sample included 123 participants (60 siblings and 63 controls), who completed a total of 5217 valid ESM observations. Control group participants completed significantly more ESM reports than the siblings [mean (s.d.)=45.6 (8.6) and 41.0 (9.3) reports, respectively; F=8.31, p=0.01]. Sample characteristics are summarized in Table 1. Sibling and control groups were well matched on demographic variables, but controls were on average 4.5 years older. With the exception of moderate differences in ESM compliance and age, the two groups did not differ significantly from each other on any of the displayed variables.

Table 1. Demographic characteristics and descriptives

CASH, Comprehensive Assessment of Symptoms and History (Andreasen et al. Reference Andreasen, Flaum and Arndt1992); CAPE, Community Assessment of Psychic Experiences; CTQ, Childhood Trauma Questionnaire; ESM, Experience Sampling Method.

a Due to rounding, percentages may not add exactly to 100%.

b For the experience sampling variables, an individual mean was first calculated over all reports; these values were then aggregated to obtain the group mean and s.d.

Cortisol levels and diurnal slope

Siblings had significantly higher cortisol levels over the ESM sampling moments than controls (Table 2). This pattern was present throughout the day, with no difference between the two groups in the steepness of the diurnal decline in cortisol secretion, as evidenced by the non-significant group×time of day effect shown in Table 2.

Table 2. Multi-level regression estimates for effects of group on cortisol level and diurnal slope

The dependent variable is log-transformed cortisol (lncort). Regression coefficients are unstandardized. Group is coded 1 for siblings and 0 for controls. The variable time of day is centred around the grand mean. Time2 was also a significant predictor of lncort (p<0.001) and is controlled for in all analyses. Recent awakening refers to samples taken within 60 min after awakening; recent food intake and smoking refer to reported occurrence of these activities in the interval between two Experience Sampling Method reports (roughly 90 min).

Cortisol reactivity to daily stress

Controls and siblings reported similar frequencies and intensities of daily negative events [mean (s.d.)=14.5 (12.3) and 13.1 (10), respectively; F=0.49, p=0.49]. There was no significant interaction between group and event stress in the model of negative affect [χ2(1)=0.03, p=0.87], but a main effect of event stress [β=0.11, 95% confidence intervals (CI) 0.087–0.122; p<0.001]. Multi-level analysis confirmed the main effect of group on cortisol (β=0.17, 95% CI 0.016–0.316, p=0.03) but revealed no main effect of event stress (β=0.01, 95% CI –0.013 to 0.034; p=0.37). However, there was a significant interaction between group and event stress [χ2(1)=4.11, p=0.04]. Stratified analyses showed an increase in cortisol following unpleasant events in the siblings (β=0.04, 95% CI 0.003–0.075, p=0.03), but no such effect in the controls (β=−0.01, 95% CI −0.04 to 0.021; p=0.53) (Fig. 1). Controlling for negative affect, a putative mediator of the stress–cortisol relationship, had no substantial effect on the results [group×event stress interaction: χ2(1)=4.71, p=0.03].

Fig. 1. Cortisol reactivity to stressful events. Modelled change (based on regression coefficient) in untransformed cortisol values (nmol/l) following daily events, according to their appraised unpleasantness (0=neutral, 3=very unpleasant), in sibling (sibs) and control groups.

Association between cortisol, psychotic experiences and negative affect

There was no main effect of psychotic experiences on momentary cortisol. However, group moderated the effect of psychotic experiences on cortisol (Table 3, Model 1). In the sibling group, increased levels of momentary psychotic experiences were associated with increased cortisol levels (β=0.18, 95% CI 0.081–0.287; p<0.001), whereas in the control group, no association was found between psychotic experiences and cortisol (β=−0.02, 95% CI −0.105 to 0.075; p=0.74). For negative affect, there was no main effect in the model predicting cortisol; however, an interaction was found with group (Table 3, Model 2). Stratified analyses indicated no significant association between negative affect and cortisol in the control group, whereas in the sibling group cortisol levels increased when participants reported higher negative affect. Finally, in a full model that included group, psychotic experiences, negative affect and the interactions between group and the two ESM variables, only the interaction between group and psychotic experiences remained significant (Table 3, Model 3).

Table 3. Multi-level estimates of the effects of momentary psychotic experiences and negative affect on cortisol, as moderated by group (siblings v. controls)

β, Unstandardized regression coefficient; s.e., standard error.

The dependent variable is lncort. The models control for time, time2, age, gender, oral contraceptive use, recent awakening, recent food intake and recent smoking.

* p<0.05, ** p<0.01, *** p<0.001.

Post-hoc exploratory analyses

To better understand the nature of the observed differences in cortisol patterns between sibling and control groups, we conducted a final series of multi-level analyses exploring the possible contribution of depression (presence or absence of lifetime diagnosis), childhood trauma (CTQ total score), overall current stress (mean unpleasantness of daily events during the sampling week) and distress (mean negative affect level) and degree of psychometric psychosis liability (CAPE trait score), by either exploring the interaction with group or adding the appropriate variable as additional predictor in the models of cortisol. Apart from some small effect size alterations, results were similar, with siblings having significantly higher cortisol levels over the ESM sampling moments and a significantly increased cortisol response following unpleasant events compared with controls. Some minor decrease of significance emerged only in the analyses controlling for psychometric psychosis liability [effect of group on cortisol: β=0.15, 95% CI −0.003 to 0.305; p=0.05; interaction between group and event stress on cortisol: χ2(1)=3.49, p=0.06].

Sensitivity analysis in non-depressed participants

Additional analyses were carried out, investigating whether diagnoses of depression impacted the results. All analyses were repeated with exclusion of participants who had a current or past diagnosis of depression (controls n=52 and relatives n=48 remained in the analyses). The results remained the same.

Discussion

The current findings indicated that siblings of individuals with psychotic disorder had higher mean cortisol levels throughout the day and greater cortisol reactivity to daily stressors than a comparison group with no family history of psychosis. In the sibling but not the control group, rated intensities of momentary psychotic experiences and negative emotions were associated with transient increases in cortisol secretion. These findings suggest that alterations in HPA axis activity previously reported in patients with established psychotic disorder, unmedicated first-episode patients, and ultra-high risk samples may also be present to some degree in healthy first-degree relatives.

The higher diurnal cortisol observed in the sibling group is consistent with reports of elevated HPA activity in patients with schizophrenia (Muck-Seler et al. Reference Muck-Seler, Pivac, Mustapic, Crncevic, Jakovljevic and Sagud2004), first-episode psychosis (Ryan et al. Reference Ryan, Sharifi, Condren and Thakore2004; Mondelli et al. Reference Mondelli, Dazzan, Hepgul, di Forti, Aas, d'Albenzio, di Nicola, Fisher, Handley, Marques, Morgan, Navari, Taylor, Papadopoulos, Aitchison, Murray and Pariante2010) and individuals at high risk for psychotic disorder (Mittal et al. Reference Mittal, Dhruv, Tessner, Walder and Walker2007; Walker et al. Reference Walker, Brennan, Esterberg, Brasfield, Pearce and Compton2010). However, other studies suggest a blunted cortisol response to stress in chronic and first episode psychosis (Jansen et al. Reference Jansen, Gispen-de Wied and Kahn2000; van Venrooij et al. Reference van Venrooij, Fluitman, Lijmer, Kavelaars, Heijnen, Westenberg, Kahn and Gispen-de Wied2010). Together, these findings may support the notion that altered activity of the HPA axis may be a marker of underlying vulnerability for psychotic disorder. The finding of greater cortisol reactivity to daily stressors in siblings compared with controls provides new information, in light of the fact that previous studies of neuroendocrine responses to stress in psychotic disorder or at-risk samples were performed in the laboratory. In the control group, we expected to find relatively smaller cortisol stress reactivity to stress compared with the sibling group. In the current study, stressors were daily hassles and minor disturbances in the flow of everyday life. In comparison with experimentally induced stress, these were insufficiently stressful to influence cortisol secretion in our control group, without underlying vulnerability for psychotic disorder. The cortisol non-response in our control group may be a sign of good psychological health, with small daily events not significantly impacting on their stress axis. We have, however, no information about the immediate cortisol response after stressful events and can therefore not eliminate the possibility of an immediate but transient cortisol response with a short recovery time in the control group. Consistent with findings in ESM studies of increased emotional and psychotic symptom reactivity to minor daily stressors in relatives of patients with psychotic disorder (Myin-Germeys et al. Reference Myin-Germeys, Delespaul and van Os2005a, Reference Myin-Germeys, Marcelis, Krabbendam, Delespaul and van Osb), the current study reveals a similar pattern with regard to cortisol responses in the sibling group, supporting the idea that elevated biological stress sensitivity may be a vulnerability marker for psychosis. However, in contrast with the previous studies, the siblings did not differ from controls in their emotional reactivity to daily life stress. The current siblings may thus represent a relatively healthy subgroup with ‘normal’ levels of emotional stress reactivity, with increased cortisol response to daily hassles possibly reflecting a protective mechanism.

Another potentially important finding is that momentary increases in psychotic symptomatology were accompanied by increases in cortisol. This association between cortisol and momentary psychotic experiences can be interpreted in two causal directions. One plausible interpretation is that the distress associated with psychotic experiences and negative emotions could induce secondary increases in cortisol levels. Several studies have shown that momentary psychotic experiences are related to increases in negative affect (Myin-Germeys et al. Reference Myin-Germeys, Nicolson and Delespaul2001a; Freeman & Garety, Reference Freeman and Garety2003; Thewissen et al. Reference Thewissen, Bentall, Oorschot, Campo, van Lierop, van Os and Myin-Germeys2010). Increases in momentary negative affect have, in turn, been linked to heightened cortisol secretion in healthy individuals (van Eck et al. Reference van Eck, Berkhof, Nicolson and Sulon1996; Jacobs et al. Reference Jacobs, Myin-Germeys, Derom, Delespaul, van Os and Nicolson2007). In the current analyses, the estimated group×psychotic experiences interaction effect on cortisol decreased only slightly and remained significant after addition of negative affect and the group×negative affect interaction as predictors. In contrast, there was no significant association between negative affect and cortisol in this complete model. This suggests that subclinical psychotic experiences may have made a greater contribution than negative affect to increased cortisol levels in the sibling group. A second interpretation of the observed association between cortisol and momentary psychotic experiences reflects the possibility that increases in cortisol are either directly involved in the pathogenesis of psychotic experiences or reflect secondary, downstream processes. For instance, cortisol secretion increases dopamine activity in certain brain regions (Dallman et al. Reference Dallman, Akana, Strack, Scribner, Pecoraro, La Fleur, Houshyar and Gomez2004). The dopaminergic system is thought to play an important role in the pathogenesis of positive psychotic symptoms (Laruelle & Abi-Dargham, Reference Laruelle and Abi-Dargham1999). Thus, heightened cortisol secretion could theoretically, via dopaminergic pathways, increase the likelihood of clinical psychotic experiences. The current finding could be interpreted as evidence for a similar association with subclinical psychotic experiences in unaffected first-degree relatives, but whether this association is causal cannot be established in an ESM study. In general, the observed interrelationships among cortisol, psychotic experiences and negative emotions need to be further explored in longitudinal or experimental designs. Studies that either induce stress and measure subsequent changes in psychotic symptoms and emotions or that induce psychotic experience and subsequent changes in cortisol are needed to answer the question of causality more conclusively.

Dysregulation of the HPA axis is unlikely to be specific for psychosis, as it is found in many disorders, in particular major depression. Moreover, cortisol levels have been found to reflect depression and anxiety, but not psychotic symptoms, in a sample at ultra-high risk for psychosis (Thompson et al. Reference Thompson, Phillips, Komesaroff, Yuen, Wood, Pantelis, Velakoulis, Yung and McGorry2007). Post-hoc analyses therefore examined whether a history of depression might explain the results; however, models that controlled for previous depressive episodes yielded similar findings. Alternatively, because siblings share not only genes but also the early rearing environment, childhood adversity – which has been associated with both psychotic disorder (Read et al. Reference Read, van Os, Morrison and Ross2005) and HPA axis abnormalities (de Bellis et al. Reference de Bellis, Chrousos, Dorn, Burke, Helmers, Kling, Trickett and Putnam1994; Tarullo & Gunnar, Reference Tarullo and Gunnar2006) – could also have influenced the current results. Although the two groups did not differ in self-reported childhood maltreatment, we also conducted post-hoc multi-level analyses to rule out the possibility that group differences in cortisol levels or reactivity were due to differential susceptibility to childhood abuse. These models revealed no association between abuse measures and cortisol in either of the two groups. Another set of analyses examined whether higher cortisol in the siblings might be due to greater overall current stress or distress. This was not the case. Finally, we found that overall psychometric psychosis liability did not significantly influence differences in cortisol patterns between control and sibling groups. Thus, in line with recent findings of cortisol abnormalities in first-episode psychosis, which could not be explained by stressful events, perceived stress or childhood trauma (Mondelli et al. Reference Mondelli, Dazzan, Hepgul, di Forti, Aas, d'Albenzio, di Nicola, Fisher, Handley, Marques, Morgan, Navari, Taylor, Papadopoulos, Aitchison, Murray and Pariante2010), the current results suggest that increased HPA axis activity may indeed reflect the underlying vulnerability to psychosis. The biological processes involved, however, remain to be elucidated.

This study has several limitations. First, use of ESM booklets instead of electronic devices means that the exact timing of participants' self-reports and saliva samples cannot be firmly established (Stone et al. Reference Stone, Shiffman, Schwartz, Broderick and Hufford2002). However, results of a study comparing self-reported and electronically monitored saliva collection times, with the same intensive, semi-random time-sampling protocol used in the current study, indicated that saliva was generally collected very close to the prescribed time and that self-reported collection times corresponded well with the electronic time stamps (Jacobs et al. Reference Jacobs, Nicolson, Derom, Delespaul, van Os and Myin-Germeys2005). Another comparative study concluded that paper and electronic diaries yield similar results (Green et al. Reference Green, Rafaeli, Bolger, Shrout and Reis2006). Second, no saliva samples were taken at the time of awakening, so that the current dataset does not allow examination of the cortisol awakening response, a measure of HPA axis activity that appears to be blunted in first-episode psychosis (Mondelli et al. Reference Mondelli, Dazzan, Hepgul, di Forti, Aas, d'Albenzio, di Nicola, Fisher, Handley, Marques, Morgan, Navari, Taylor, Papadopoulos, Aitchison, Murray and Pariante2010). Third, this study focused solely on the circulating hormone cortisol and can thus provide no insight into underlying mechanisms at higher levels of the HPA axis. Fourth, the interval between cortisol sampling and event occurrence is relevant (van Eck et al. Reference van Eck, Berkhof, Nicolson and Sulon1996). However, there is no reason to expect systematic differences between groups on the time interval between stressor and time of sampling. Therefore, we are confident that variability in time lag does not question the validity of our analysis on group differences. Moreover, a potentially stressful event could have occurred between 15 and 90 min before sampling of cortisol. As the half-life of cortisol is about 1 h, we still expect to find traces of potential stressors, even when they occurred some time ago. Finally, caution is warranted in generalizing results from the current adult sibling sample to other groups at increased genetic risk for psychosis. Compared with children of parents with a psychotic disorder and others identified as being at ultra-high risk for developing a disorder, the siblings included in this study were older; in most cases, past the age when onset of psychosis is most likely to occur. The nature and extent of HPA axis abnormalities in healthy siblings may differ from those described in at-risk and ultra-high risk adolescent samples. Therefore, it cannot be eliminated that the increased cortisol reactivity in our sibling group reflects a protective rather than a risk factor. On the other hand, it might be that even with a suboptimal biological reactivity, siblings manage to cope better with stress and/or have other resilience factors protecting them from psychotic disorder.

The current study also had some specific strengths. In particular, the repeated sampling of salivary cortisol over 6 days takes into account the well-known but often ignored unreliability of cortisol measures obtained at infrequent intervals (Hruschka et al. Reference Hruschka, Kohrt and Worthman2005). Multiple cortisol measures per person were complemented by a relatively large number of participants. Use of multi-level modelling allowed assessment of within-person associations between cortisol and subjective experience in real time and real-life contexts. Although cortisol measures in both groups were within the normal range, intensive sampling revealed a consistent pattern of heightened HPA activity in the siblings. Taken together, the current findings lend additional credence to the hypothesis that irregularities in HPA axis activity are involved in psychosis vulnerability, broadening the spectrum of vulnerability to include siblings without demonstrable psychometric risk markers.

Appendix. Genetic Risk and Outcome in Psychosis (G.R.O.U.P.) investigators

R. S. Kahn, D. H. Linszen, J. van Os, D. Wiersma, R. Bruggeman, W. Cahn, L. de Haan, L. Krabbendam, I. Myin-Germeys.

Acknowledgements

Inez Myin-Germeys was supported by a 2006 NARSAD Young Investigator award and by the Dutch Medical Council (VENI and VIDI grant). This work was also sponsored by the Dutch Organization for Scientific Research NWO (G.R.O.U.P.). The authors thank research assistants Truda Driesen and Frieda Goethem for their work on this project.

Declaration of Interest

None.

References

Albus, M, Ackenheil, M, Engel, RR, Muller, F (1982). Situational reactivity of autonomic functions in schizophrenic patients. Psychiatry Research 6, 361370.CrossRefGoogle ScholarPubMed
Andreasen, NC, Flaum, M, Arndt, S (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615623.CrossRefGoogle ScholarPubMed
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, fourth edition. American Psychiatric Association: Washington, DC.Google Scholar
Bernstein, DP, Stein, JA, Newcomb, MD, Walker, E, Pogge, D, Ahluvalia, T, Stokes, J, Handelsman, L, Medrano, M, Desmond, D, Zule, W (2003). Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse & Neglect 27, 169190.CrossRefGoogle ScholarPubMed
Breier, A, Wolkowitz, OM, Doran, AR, Bellar, S, Pickar, D (1988). Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers. Psychiatry Research 25, 187194.CrossRefGoogle ScholarPubMed
Brenner, K, Liu, A, Laplante, DP, Lupien, S, Pruessner, JC, Ciampi, A, Joober, R, King, S (2009). Cortisol response to a psychosocial stressor in schizophrenia: blunted, delayed, or normal? Psychoneuroendocrinology 34, 859868.CrossRefGoogle ScholarPubMed
Csikszentmihalyi, M, Larson, R (1987). Validity and reliability of the Experience-Sampling Method. Journal of Nervous and Mental Disease 175, 526536.CrossRefGoogle ScholarPubMed
Dallman, MF, Akana, SF, Strack, AM, Scribner, KS, Pecoraro, N, La Fleur, SE, Houshyar, H, Gomez, F (2004). Chronic stress-induced effects of corticosterone on brain: direct and indirect. Annals of the New York Academy of Sciences 1018, 141150.CrossRefGoogle ScholarPubMed
de Bellis, MD, Chrousos, GP, Dorn, LD, Burke, L, Helmers, K, Kling, MA, Trickett, PK, Putnam, FW (1994). Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. Journal of Clinical Endocrinology & Metabolism 78, 249255.Google ScholarPubMed
Delespaul, P, deVries, M, van Os, J (2002). Determinants of occurrence and recovery from hallucinations in daily life. Social Psychiatry and Psychiatric Epidemiology 37, 97–104.CrossRefGoogle ScholarPubMed
Freeman, D, Garety, PA (2003). Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations. Behavioral Research and Therapy 41, 923947.CrossRefGoogle ScholarPubMed
Garner, B, Pariante, CM, Wood, SJ, Velakoulis, D, Phillips, L, Soulsby, B, Brewer, WJ, Smith, DJ, Dazzan, P, Berger, GE, Yung, AR, van den Buuse, M, Murray, R, McGorry, PD, Pantelis, C (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry 58, 417423.CrossRefGoogle ScholarPubMed
Goldstein, JM, Seidman, LJ, Makris, N, Ahern, T, O'Brien, LM, Caviness, VS Jr., Kennedy, DN, Faraone, SV, Tsuang, MT (2007). Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biological Psychiatry 61, 935945.Google Scholar
Green, AS, Rafaeli, E, Bolger, N, Shrout, PE, Reis, HT (2006). Paper or plastic? Data equivalence in paper and electronic diaries. Psychological Methods 11, 87–105.CrossRefGoogle ScholarPubMed
G.R.O.U.P. (2010). Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Archives of General Psychiatry 68, 138147.Google Scholar
Hanssen, M, Bak, M, Bijl, R, Vollebergh, W, van Os, J (2005). The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 44, 181191.CrossRefGoogle ScholarPubMed
Hruschka, DJ, Kohrt, BA, Worthman, CM (2005). Estimating between- and within-individual variation in cortisol levels using multilevel models. Psychoneuroendocrinology 30, 698714.Google Scholar
Jacobs, N, Myin-Germeys, I, Derom, C, Delespaul, P, van Os, J, Nicolson, NA (2007). A momentary assessment study of the relationship between affective and adrenocortical stress responses in daily life. Biological Psychology 74, 6066.CrossRefGoogle ScholarPubMed
Jacobs, N, Nicolson, NA, Derom, C, Delespaul, P, van Os, J, Myin-Germeys, I (2005). Electronic monitoring of salivary cortisol sampling compliance in daily life. Life Sciences 76, 24312443.CrossRefGoogle ScholarPubMed
Jansen, LM, Gispen-de Wied, CC, Gademan, PJ, De Jonge, RC, van der Linden, JA, Kahn, RS (1998). Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophrenia Research 33, 8794.CrossRefGoogle ScholarPubMed
Jansen, LM, Gispen-de Wied, CC, Kahn, RS (2000). Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berlin) 149, 319325.CrossRefGoogle ScholarPubMed
Koolschijn, PC, van Haren, NE, Hulshoff Pol, HE, Kahn, RS (2008). Hypothalamus volume in twin pairs discordant for schizophrenia. European Neuropsychopharmacology 18, 312315.CrossRefGoogle ScholarPubMed
Laruelle, M, Abi-Dargham, A (1999). Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. Journal of Psychopharmacology 13, 358371.CrossRefGoogle ScholarPubMed
Marcelis, M, Cavalier, E, Gielen, J, Delespaul, P, van Os, J (2004). Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization? Psychological Medicine 34, 11031111.CrossRefGoogle ScholarPubMed
Meltzer, HY, Koenig, JI, Nash, JF, Gudelsky, GA (1989). Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs. Acta Psychiatrica Scandinavica (Suppl.) 352, 2429.CrossRefGoogle ScholarPubMed
Mittal, VA, Dhruv, S, Tessner, KD, Walder, DJ, Walker, EF (2007). The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol. Biological Psychiatry 61, 11791186.CrossRefGoogle ScholarPubMed
Mondelli, V, Dazzan, P, Gabilondo, A, Tournikioti, K, Walshe, M, Marshall, N, Schulze, KK, Murray, RM, McDonald, C, Pariante, CM (2008). Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 33, 10041012.Google Scholar
Mondelli, V, Dazzan, P, Hepgul, N, di Forti, M, Aas, M, d'Albenzio, A, di Nicola, M, Fisher, H, Handley, R, Marques, TR, Morgan, C, Navari, S, Taylor, H, Papadopoulos, A, Aitchison, KJ, Murray, RM, Pariante, CM (2010). Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophrenia Research 116, 234242.CrossRefGoogle ScholarPubMed
Muck-Seler, D, Pivac, N, Mustapic, M, Crncevic, Z, Jakovljevic, M, Sagud, M (2004). Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Research 127, 217226.CrossRefGoogle ScholarPubMed
Myin-Germeys, I, Delespaul, P, van Os, J (2005 a). Behavioural sensitization to daily life stress in psychosis. Psychological Medicine 35, 733741.CrossRefGoogle ScholarPubMed
Myin-Germeys, I, Marcelis, M, Krabbendam, L, Delespaul, P, van Os, J (2005 b). Subtle fluctuations in psychotic phenomena as functional states of abnormal dopamine reactivity in individuals at risk. Biological Psychiatry 58, 105110.CrossRefGoogle ScholarPubMed
Myin-Germeys, I, Nicolson, NA, Delespaul, PA (2001 a). The context of delusional experiences in the daily life of patients with schizophrenia. Psychological Medicine 31, 489498.CrossRefGoogle ScholarPubMed
Myin-Germeys, I, Oorschot, M, Collip, D, Lataster, J, Delespaul, P, van Os, J (2009). Experience sampling research in psychopathology: opening the black box of daily life. Psychological Medicine 39, 15331547.Google Scholar
Myin-Germeys, I, van Os, J, Schwartz, JE, Stone, AA, Delespaul, PA (2001 b). Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 58, 11371144.Google Scholar
Nicolson, N (2007). Measurement of cortisol. In Handbook of Physiological Research Methods in Health Psychology(Luecken, L. J. and Gallo, L. C.), pp. 3774. Sage Publications: Thousand Oaks, CA.Google Scholar
NIMH Genetics Initiative (1992). Family Interview for Genetic Studies (FIGS). National Institute of Mental Health: Rockville, MD.Google Scholar
Pariante, CM (2008). Pituitary volume in psychosis: the first review of the evidence. Journal of Psychopharmacology 22, 7681.CrossRefGoogle ScholarPubMed
Peeters, F, Nicolson, NA, Berkhof, J (2004). Levels and variability of daily life cortisol secretion in major depression. Psychiatry Research 126, 113.CrossRefGoogle ScholarPubMed
Read, J, van Os, J, Morrison, AP, Ross, CA (2005). Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatrica Scandinavica 112, 330350.CrossRefGoogle ScholarPubMed
Ryan, MC, Sharifi, N, Condren, R, Thakore, JH (2004). Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 29, 10651070.Google Scholar
Soliman, A, O'Driscoll, GA, Pruessner, J, Holahan, AL, Boileau, I, Gagnon, D, Dagher, A (2008). Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology 33, 20332041.Google Scholar
StataCorp (2009). STATA/SE Statistical Software, Release 11. StataCorp: College Station, TX.Google Scholar
Stone, AA, Shiffman, S, Schwartz, JE, Broderick, JE, Hufford, MR (2002). Patient non-compliance with paper diaries. British Medical Journal 324, 11931194.CrossRefGoogle ScholarPubMed
Sulon, J, Demey-Ponsart, L, Beauduin, P, Sodoyez, JC (1978). Radioimmunoassay of corticosterone, cortisol and cortisone: their application to human cord and maternal plasma. Journal of Steroid Biochemistry and Molecular Biology 9, 671676.CrossRefGoogle ScholarPubMed
Tarullo, AR, Gunnar, MR (2006). Child maltreatment and the developing HPA axis. Hormones and Behavior 50, 632639.CrossRefGoogle ScholarPubMed
Thewissen, V, Bentall, RP, Oorschot, M, Campo, JA, van Lierop, T, van Os, J, Myin-Germeys, I (2010). Emotions, self-esteem, and paranoid episodes: an experience sampling study. British Journal of Clinical Psychology, doi: 10.1348/014466510X508677, published online 2 March 2011.Google Scholar
Thompson, KN, Phillips, LJ, Komesaroff, P, Yuen, HP, Wood, SJ, Pantelis, C, Velakoulis, D, Yung, AR, McGorry, PD (2007). Stress and HPA-axis functioning in young people at ultra high risk for psychosis. Journal of Psychiatric Research 41, 561569.Google Scholar
van Eck, M, Berkhof, H, Nicolson, N, Sulon, J (1996). The effects of perceived stress, traits, mood states, and stressful daily events on salivary cortisol. Psychosomatic Medicine 58, 447458.Google Scholar
van Venrooij, JA, Fluitman, SB, Lijmer, JG, Kavelaars, A, Heijnen, CJ, Westenberg, HG, Kahn, RS, Gispen-de Wied, CC (2010). Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin, doi: 10.1093/schbul/sbq062, published online 17 June 2010.Google Scholar
van Winkel, R, Stefanis, NC, Myin-Germeys, I (2008). Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophrenia Bulletin 34, 10951105.Google Scholar
Walker, E, Mittal, V, Tessner, K (2008). Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annual Review of Clinical Psychology 4, 189216.CrossRefGoogle ScholarPubMed
Walker, EF, Brennan, PA, Esterberg, M, Brasfield, J, Pearce, B, Compton, MT (2010). Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. Journal of Abnormal Psychology 119, 401408.CrossRefGoogle ScholarPubMed
Walker, EF, Walder, DJ, Reynolds, F (2001). Developmental changes in cortisol secretion in normal and at-risk youth. Development and Psychopathology 13, 721732.CrossRefGoogle ScholarPubMed
Walsh, P, Spelman, L, Sharifi, N, Thakore, JH (2005). Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release. Psychoneuroendocrinology 30, 431437.Google Scholar
Wik, G (1995). Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood. Journal of Endocrinology 144, 425429.CrossRefGoogle ScholarPubMed
Wright, IC, Rabe-Hesketh, S, Woodruff, PW, David, AS, Murray, RM, Bullmore, ET (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry 157, 1625.Google Scholar
Figure 0

Table 1. Demographic characteristics and descriptives

Figure 1

Table 2. Multi-level regression estimates for effects of group on cortisol level and diurnal slope

Figure 2

Fig. 1. Cortisol reactivity to stressful events. Modelled change (based on regression coefficient) in untransformed cortisol values (nmol/l) following daily events, according to their appraised unpleasantness (0=neutral, 3=very unpleasant), in sibling (sibs) and control groups.

Figure 3

Table 3. Multi-level estimates of the effects of momentary psychotic experiences and negative affect on cortisol, as moderated by group (siblings v. controls)